SE0102887D0 - New formulation - Google Patents
New formulationInfo
- Publication number
- SE0102887D0 SE0102887D0 SE0102887A SE0102887A SE0102887D0 SE 0102887 D0 SE0102887 D0 SE 0102887D0 SE 0102887 A SE0102887 A SE 0102887A SE 0102887 A SE0102887 A SE 0102887A SE 0102887 D0 SE0102887 D0 SE 0102887D0
- Authority
- SE
- Sweden
- Prior art keywords
- dosage form
- relates
- active substance
- extended release
- release oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102887A SE0102887D0 (sv) | 2001-08-29 | 2001-08-29 | New formulation |
CA002457341A CA2457341A1 (en) | 2001-08-29 | 2002-08-28 | A new extended release oral dosage form |
BR0212167-0A BR0212167A (pt) | 2001-08-29 | 2002-08-28 | Forma de dosagem oral de liberação prolongada, uso da mesma, método para a prevenção e/ou tratamento de distúrbios e perturbações médicas, e, processo para a fabricação de uma forma de dosagem de liberação prolongada |
US10/488,125 US20040197404A1 (en) | 2001-08-29 | 2002-08-28 | Extended release oral dosage form |
PCT/SE2002/001541 WO2003017983A1 (en) | 2001-08-29 | 2002-08-28 | A new extended release oral dosage form |
IL16037102A IL160371A0 (en) | 2001-08-29 | 2002-08-28 | A new extended release oral dosage form |
CNA028168712A CN1549705A (zh) | 2001-08-29 | 2002-08-28 | 新的缓释口服剂型 |
EP02763155A EP1423099A1 (en) | 2001-08-29 | 2002-08-28 | A new extended release oral dosage form |
HU0401599A HUP0401599A3 (en) | 2001-08-29 | 2002-08-28 | Extended release oral dosage form |
KR10-2004-7002920A KR20040032977A (ko) | 2001-08-29 | 2002-08-28 | 신규 지연 방출 경구 투여 제형 |
JP2003522503A JP2005504052A (ja) | 2001-08-29 | 2002-08-28 | 新規の徐放性経口製剤 |
MXPA04001805A MXPA04001805A (es) | 2001-08-29 | 2002-08-28 | Nueva forma de dosificacion oral de liberacion prolongada. |
ZA200401547A ZA200401547B (en) | 2001-08-29 | 2004-02-25 | A new extended release oral dosage form. |
NO20040857A NO20040857L (no) | 2001-08-29 | 2004-02-26 | Ny oral forlenget frigivelses doseringsform. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102887A SE0102887D0 (sv) | 2001-08-29 | 2001-08-29 | New formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0102887D0 true SE0102887D0 (sv) | 2001-08-29 |
Family
ID=20285178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0102887A SE0102887D0 (sv) | 2001-08-29 | 2001-08-29 | New formulation |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040197404A1 (sv) |
EP (1) | EP1423099A1 (sv) |
JP (1) | JP2005504052A (sv) |
KR (1) | KR20040032977A (sv) |
CN (1) | CN1549705A (sv) |
BR (1) | BR0212167A (sv) |
CA (1) | CA2457341A1 (sv) |
HU (1) | HUP0401599A3 (sv) |
IL (1) | IL160371A0 (sv) |
MX (1) | MXPA04001805A (sv) |
NO (1) | NO20040857L (sv) |
SE (1) | SE0102887D0 (sv) |
WO (1) | WO2003017983A1 (sv) |
ZA (1) | ZA200401547B (sv) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8852632B2 (en) * | 2004-12-03 | 2014-10-07 | Merck Sharp & Dohme Corp. | Pharmaceutical formulation containing a release rate controlling composition |
WO2007055329A1 (ja) | 2005-11-11 | 2007-05-18 | Asahi Kasei Chemicals Corporation | 徐放性固形製剤 |
GB0616794D0 (en) * | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
EP2341912B1 (en) | 2008-09-05 | 2014-01-22 | Supernus Pharmaceuticals, Inc. | Method of treatment of attention deficit/hyperactivity disorder (adhd) |
EP2780016A4 (en) | 2011-11-07 | 2015-08-05 | Diakron Pharmaceuticals Inc | EXTENDED RELEASE FORMULATION OF DIRECT THROMBIN INHIBITOR |
ES2950875T3 (es) | 2012-02-08 | 2023-10-16 | Supernus Pharmaceuticals Inc | Formulaciones de liberación modificada de viloxazina |
US10071058B2 (en) * | 2012-03-07 | 2018-09-11 | Santarus, Inc. | Controlled-release solid dosage forms of mesalamine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
US4837032A (en) * | 1986-02-04 | 1989-06-06 | Farval Ag | Theophylline sustained release tablet |
GB8624213D0 (en) * | 1986-10-09 | 1986-11-12 | Sandoz Canada Inc | Sustained release pharmaceutical compositions |
PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
SE510305C2 (sv) * | 1997-05-30 | 1999-05-10 | Astra Ab | Nytt salt |
AR035642A1 (es) * | 2000-05-26 | 2004-06-23 | Pharmacia Corp | Uso de una composicion de celecoxib para el alivio rapido del dolor |
-
2001
- 2001-08-29 SE SE0102887A patent/SE0102887D0/sv unknown
-
2002
- 2002-08-28 US US10/488,125 patent/US20040197404A1/en not_active Abandoned
- 2002-08-28 JP JP2003522503A patent/JP2005504052A/ja active Pending
- 2002-08-28 MX MXPA04001805A patent/MXPA04001805A/es unknown
- 2002-08-28 KR KR10-2004-7002920A patent/KR20040032977A/ko not_active Application Discontinuation
- 2002-08-28 EP EP02763155A patent/EP1423099A1/en not_active Withdrawn
- 2002-08-28 WO PCT/SE2002/001541 patent/WO2003017983A1/en not_active Application Discontinuation
- 2002-08-28 IL IL16037102A patent/IL160371A0/xx unknown
- 2002-08-28 CA CA002457341A patent/CA2457341A1/en not_active Abandoned
- 2002-08-28 CN CNA028168712A patent/CN1549705A/zh active Pending
- 2002-08-28 BR BR0212167-0A patent/BR0212167A/pt not_active IP Right Cessation
- 2002-08-28 HU HU0401599A patent/HUP0401599A3/hu unknown
-
2004
- 2004-02-25 ZA ZA200401547A patent/ZA200401547B/en unknown
- 2004-02-26 NO NO20040857A patent/NO20040857L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2457341A1 (en) | 2003-03-06 |
US20040197404A1 (en) | 2004-10-07 |
EP1423099A1 (en) | 2004-06-02 |
IL160371A0 (en) | 2004-07-25 |
ZA200401547B (en) | 2004-11-17 |
BR0212167A (pt) | 2004-07-20 |
WO2003017983A1 (en) | 2003-03-06 |
HUP0401599A3 (en) | 2007-03-28 |
HUP0401599A2 (hu) | 2004-11-29 |
KR20040032977A (ko) | 2004-04-17 |
NO20040857L (no) | 2004-04-19 |
CN1549705A (zh) | 2004-11-24 |
MXPA04001805A (es) | 2004-07-08 |
JP2005504052A (ja) | 2005-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA88270C2 (ru) | Фармацевтический препарат и его применение для профилактики удара, диабета | |
NO20055880L (no) | Memantin orale doseringsformer | |
PL374443A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
SG146638A1 (en) | Pharmaceutical delivery system | |
ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
SE0102887D0 (sv) | New formulation | |
EP1262197A3 (en) | Combination treatment for sleep disorders including sleep apnea | |
HUP0203682A2 (hu) | Eljárás foszfodiészteráz-4 inhibitor beadására | |
PL1656131T3 (pl) | Zastosowanie betainy w leczeniu chromania przestankowego | |
PL368686A1 (en) | Novel aminobenzoephenones | |
NZ535611A (en) | Pharmaceutical composition of a PDE4 or a PDE3/4 inhibitor and a histamine receptor antagonist | |
SE9902597D0 (sv) | New use | |
MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
HUP0301408A2 (hu) | Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására | |
SE0102886D0 (sv) | New formulation | |
SE0102888D0 (sv) | New formulation | |
EA200901145A1 (ru) | Применение рибофлавина в лечении гипертензии | |
HK1075390A1 (en) | Citalopram for the treatment of elevated blood pressure | |
WO2004043486A8 (en) | An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism | |
DE60235965D1 (de) | Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz | |
SE0002354D0 (sv) | New formulation | |
ATE284696T1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
MD2491F1 (en) | Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment | |
ATE296640T1 (de) | Methode und mittel zur behandlung eines post- poliosyndroms | |
DE60113895D1 (de) | Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose |